Cardiology and Cardiothoracic-Vascular Surgery

Research and Education > TriHealth Hatton Research Institute

In the early 1970s, Good Samaritan Hospital began to participate in prominent cardiac research efforts, thus establishing a reputation for leadership in cardiology. The TriHealth Hatton Research Institute now builds upon that reputation by helping to expand the robust group of cardiac and cardiothoracic/vascular clinical trials at Good Samaritan and Bethesda North hospitals. Specifically, the TriHealth Hatton Research Institute assists researchers in identifying and conducting research studies, as well as maintaining the proper compliance measures.

Both Bethesda North Hospital and Good Samaritan Hospital are composed of a research supervisor, a research / regulatory assistant, and research nurses who serve as study coordinators. The TriHealth Hatton Research Institute's cardiac and cardiothoracic/vascular research team has an average of 20 years of experience in critical care nursing.

The cardiac and cardiothoracic/vascular clinical trials listed below are currently being conducted to target the prevention or treatment of specific diseases and promote heart and vascular health. For more information, please call the appropriate contact person.


Current Clinical Trials

Cardiology and Cardiothoracic-Vascular Surgery

 

Pivotal Study of a Dual Epicardial & Endocardial Procedure (DEEP) Approach for Treatment of Subjects with Persistent or Long Standing Persistent or Long Standing Persistent Atrial Fibrillation with Radiofrequency Ablation. Learn more .

Principal Investigator and Contact information: 
J. Michael Smith, MD and Gaurang Gandhi, MD
513 865 5120 or 513 745 9800

Study Coordinator and Contact information: 
Carol Krabbe, RN
513 862 2877
carol_krabbe@TriHealth.com

Multicenter, Observational, Post-Market, Real World Study to Assess Outcomes of Patients Treated with the AFX System Compared to other EVAR Devices for Endovascular Abdominal Aortic Aneurysm Repair (LEOPARD). Learn more .

Principal Investigator and Contact information: 
Patrick Muck, MD
513 865 9898

Study Coordinator and Contact information:
Susan Reilly, RN
513 862 2877
susan_reilly2@TriHealth.com

Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D. Learn more .

Principal Investigator and Contact information: 
John Wilson, MD
513 861 1260

Study Coordinator and Contact information:
Carol Krabbe, RN
513 862 2877
carol_krabbe@TriHealth.com

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk. Learn more .

Principal Investigator and Contact information: 
Freidoon Ghazi, MD
513 861 1260

Study Coordinator and Contact information: 
Marien Bryson, RN
513 862 2877
marien_bryson@TriHealth.com

AdaptResponse Clinical Trial. Learn more.

Principal Investigator and Contact information:
Gaurang Gandhi, MD
513 745 9800 

Study Coordinator and Contact information:
Sue Dorroh, RN
513 865 1148
sue_dorroh@TriHealth.com

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis (SFA ISR). Learn more .

Principal Investigator and Contact information:
Patrick Muck, MD
513 865 9898

Study Coordinator and Contact information:
Susan Reilly, RN
513 862 2877
susan_reilly2@TriHealth.com

Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries. Learn more .

Principal Investigator and Contact information:
Patrick Muck, MD
513 865 9898

Study Coordinator and Contact information:
Susan Reilly, RN
513 862 2877
susan_reilly2@TriHealth.com

Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction (VIVO Clinical Study). Learn more.

Principal Investigator and Contact information:
Patrick Muck, MD
513 865 9898

Study Coordinator and Contact information:
Susan Reilly, RN
513 862 2877
susan_reilly2@TriHealth.com

QP ExCELs Sentus QP – Extended CRT Evaluation with Quadripolar Left Ventricular Leads. Learn more .

Principal Investigator and Contact information:
Marshall Winner, MD
513 861 1260

Study Coordinator and Contact information:
Carol Krabbe, RN
513 862 2877
Carol_Krabbe@TriHealth.com

A Randomized, Double-Blind, Event-Driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure (COMMANDER HF). Learn more .

Principal Investigator and Contact information:
Freidoon Ghazi, MD
513 861 1260

Study Coordinator and Contact information:
Marien Bryson, RN
513 862 2877
Marien_Bryson@TriHealth.com

Transcatheter Aortic Valve Replacement with the Medtronic Transcatheter Aortic Valve Replacement System in Patients at Low Risk for Surgical Aortic Valve Replacement. Learn more .

Principal Investigator and Contact information:
Puvi Seshiah, MD & J. Michael Smith, MD
513 861 1260 or 513 865 5120

Study Coordinator and Contact information:
Susan Reilly, RN
513 862 2877
Susan_Reilly2@TriHealth.com

A Prospective, Multicenter, Single-Arm Study Designed to Assess the Safety of 3-Month Dual Antiplatelet Therapy (DAPT) in Subjects at High Risk for Bleeding Undergoing Percutaneous Coronary Intervention (PCI) with the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (EVOLVE). Learn more .

Principal Investigator and Contact information:
Dogan Temizer, MD
513 861 1260

Study Coordinator and Contact information:
Melissa Banuelos, RN
513 862 2877
Melissa_Banuelos@TriHealth.com

Prospective Registry on User Experience with the RHYTHMIA Mapping System for Ablation Procedures (TRUE HD). Learn more .

Principal Investigator and Contact information:
Marshall Winner, MD
513 861 1260

Study Coordinator and Contact information:
Carol Krabbe, RN
513 862 2877
Carol_Krabbe@TriHealth.com

Assessment of the Gore Excluder Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms. Learn more .

Principal Investigator and Contact information:
Patrick Muck, MD
513 861 1260

Study Coordinator and Contact information:
Sue Dorroh, RN
513 865 1148
Sue_Dorroh@TriHealth.com

We are physicians, hospitals and communities working together to help you live better.